In the latest market close, Gilead Sciences (GILD) reached $92.38, with a +1.52% movement compared to the previous day. The stock lagged the S&P 500's daily gain of 1.83%. Meanwhile, the Dow gained 1.

Gilead Sciences (GILD) ended the recent trading session at $89.14, demonstrating a -1.64% swing from the preceding day's closing price. The stock trailed the S&P 500, which registered a daily gain of ...

Right now, Gilead Sciences is sporting a Zacks Rank of #2 (Buy), while Vertex ... Investors use the P/B ratio to look at a stock's market value versus its book value, which is defined as total ...

Shares of Gilead Sciences Inc. GILD rallied 1.52% to $92.38 Wednesday, on what proved to be an all-around great trading ...

The Zacks Medical - Biomedical and Genetics industry, to which Gilead belongs, has lost 7.6% over this period. Now the key question is: Where could the stock be headed in the near term?

Gilead Sciences (GILD) has recently been on Zacks.com's list of the most searched stocks. Therefore, you might want to consider some of the key factors that could influence the stock's performance in ...

The stock's change was more than the S&P 500's daily ... Over the past month, the Zacks Consensus EPS estimate has shifted 0.62% downward. Gilead Sciences is currently sporting a Zacks Rank of #3 ...

Here at Zacks, we focus on our proven ranking ... and we can clearly see that GILD is an impressive value stock right now. History suggests their performance could be sensational.

Gilead Sciences (GILD) could be a solid addition to your portfolio given its recent upgrade to a Zacks Rank #2 (Buy). This rating change essentially reflects an upward trend in earnings estimates -- ...